Drug intelligence / Profile preview

Hepapon DS

Development stage
Unknown
Lead developer
Makshi Healthcare
Modality
Small Molecules
Administration
Oral
01

Overview

Hepapon DS is a hepatoprotective medication marketed by Makshi Healthcare, primarily indicated for the management of various liver disorders including fatty liver, alcoholic liver disease, and chronic hepatitis. It functions as a liver tonic to support hepatic detoxification and regeneration. The formulation typically combines silymarin, a flavonolignan complex derived from milk thistle (*Silybum marianum*), with L-ornithine L-aspartate (LOLA). Silymarin provides antioxidant and anti-inflammatory effects while stabilizing hepatocyte membranes and stimulating DNA-directed RNA polymerase I to enhance protein synthesis and tissue repair. L-ornithine L-aspartate acts as a substrate for the urea cycle and glutamine synthetase, effectively reducing elevated blood ammonia levels associated with hepatic dysfunction. This dual-action approach helps in detoxifying the liver and improving overall metabolic function in the context of hepatic insufficiency.

Brand names
Hepapon DSHepapon DS-Makshi
02

Targets

Pol I (RNA polymerase I)CPS1 (Carbamoyl phosphate synthetase I)GLUL (Glutamine synthetase)

Beyond the preview

Go deeper on Hepapon DS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepapon DS.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call